ArticleRespiratory research2025

Impact of elexacaftor/tezacaftor/ivacaftor (ETI) on the prescription refill rate (PRR) for inhaled medications in people with CF: an Italian multicenter analysis.

Andrea Gramegna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.